Fw: Biomaterials availability in the U.S. - published 1998

[Guest guest]

----- Original Message -----

From: " Kathi " <pureheart@...>

Sent: Sunday, December 29, 2002 8:10 AM

Subject: Re: Biomaterials availability in the U.S. - published 1998

> Looks like most of us have the same reaction to this article.........

>

> Did I read correctly -- " would advocate for patients??? " Wonder how much

>

> this author received for writing this article??

>

> Carolyn

>

>

> There was a law passed before 1998 that no one could

> sue the component and raw materials manufacturers unless

> they also sold the finished product. Dow sold the finished

> product. If the manufacturer's in the article were sued

> it was by Dow, not by any claimants. Maybe another

> manufacturer can do that. I think this article is like

> many--b***s***.

>

> Bonnie

>

> Remember the post or e-mail to me re the biomaterials

> in the US and I responded that there was some kind of

> law passed protecting the suppliers? I ran across it

> this morning. . .it's called the Biomaterials Access

> Assurance Act of 1997 and it was intoduced to Congress

> by McCain, Leiberman and Gekas.

>

> " Under this Act, suppliers of raw materials used in the

> manufacture of implants (including shunts) can not be

> held liable in product liability claims when they are not

> involved in the manufacture or sale of the medical device

> alleged to cause harm. "

>

> " The Biomaterials Access Assurance Act of 1997 is an important

> step forward in insuring that thousands of individuals who depend

> on sunts and other life-saving implantable medical devices will

> never have to worry about their availability in the future. "

>

>

> That's why I thought the article was bs--I can't remember all of it, but

>

> my thoughts go to public relations firms representing insurance

> companies

> for some reason.

>

> Bonnie

>

> RE:

> ----- Original Message -----

> From: " Kathi " <pureheart@...>

> Sent: Friday, December 27, 2002 1:09 PM

> Subject: Biomaterials availability in the U.S. - published 1998

>

>

> > Biomaterials availability in the U.S.

> > Pierre M. Galletti *

> > Brown University, Providence, Rhode Island 02913

> >

> >

> > *Correspondence to Pierre M. Galletti, Brown University, Providence,

> > Rhode Island 02913

> >

> > Abstract

> >

> > Slowly but inexorably the commodity materials that constitute over

> 95%

> > of implantable devices are being withdrawn from the medical market.

> U.S.

> > manufacturers operate on accumulated reserves and

> > therefore are reluctant to say precisely when they will stop

> > fabrication. Nonetheless, thousands and perhaps millions of people

> [are]

> > at risk of not being able to receive the most commonplace medical

> > treatments1: vascular grafts, cardiac valves, hip joint prostheses,

> > hydrocephalus shunts.

> >

> >

> >

> > Journal of Biomedical Materials Research

> > Volume 32, Issue 3, 1996. Pages: 289-291

> >

> > Journal of Biomedical Materials Research

> > Published Online: 6 Dec 1998

>